Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Ark Therapeutics Group plc    AKT   GB0034251727

 SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisions 
Company
Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer.The company was founded by Peter Stephen Keen, John W. Martin, Seppo... 
Sector
Pharmaceuticals
Calendar
03/11Earnings Release
More about the company
Financials ( GBP)
Sales 2013 -
EBIT 2013 -
Net income 2013 -
Debt 2013 -
Yield 2013 -
Sales 2014 -
EBIT 2014 -
Net income 2014 -
Debt 2014 -
Yield 2014 -
PER 2013 0,03
PER 2014 -
Capi. / Sales 2013 0
Capi. / Sales 2014 -
Capitalization 3,98 M
More Financials
Latest news on ARK THERAPEUTICS GROUP PLC
02/03 ARK THERAPEUTICS : Seals Deal To Buy Majority Stake In Premier Veterinary (CORRE..
01/28 ARK THERAPEUTICS : Seals Deal To Buy Majority Stake In Premier Veterinary
01/12 ALLERGY THERAPEUTICS : To Post 4% Rise In First-Half Revenue
2014 ARK THERAPEUTICS GROUP PLC : Reverse Split: 1 for 100
2014 ARK THERAPEUTICS : Posting of Circular
2014 ARK THERAPEUTICS : Says Proposed Reverse Takeover Plan Progressing Well
2014 ARK THERAPEUTICS : Half Yearly Report and Change of Registered Office
2014 ARK THERAPEUTICS : Results of AGM and Board Changes
More news
Sector news Generic Pharmaceuticals
05:01a SALIX PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Commences An Investigati..
02/27 JOHNSON & JOHNSON : Announces Formation of New Health and Wellness Platform Desi..
02/27 ABBOTT LABORATORIES : Mylan closes $5.3B tax-lowering deal with Abbott Labs
Plus d'actualités du secteur Generic Pharmaceuticals


Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF